Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,995,859
in 7 filings, $6.0M under 10b5-1 plans

Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-15 Azamian Bobak R. President/CEO and Board Chair Exercise or conversion · Restricted Stock Units −11,299 33,898
2023-03-15 Greenstein Leonard M. Chief Financial Officer Exercise or conversion +4,462 38,751
2023-03-15 Greenstein Leonard M. Chief Financial Officer Exercise or conversion · Restricted Stock Units −4,462 13,388
2023-03-15 LINK WILLIAM J PHD Director Other disposition −215,575 215,576
2023-03-15 LINK WILLIAM J PHD Director Other acquisition +52,194 68,673
2023-03-15 Holdbrook Mark J. V.P., Clinical Affairs Exercise or conversion +2,653 3,764
2023-03-15 Holdbrook Mark J. V.P., Clinical Affairs Exercise or conversion · Restricted Stock Units −2,653 7,959
2023-03-15 Wahl Bryan General Counsel Exercise or conversion +4,790 18,513
2023-03-15 Wahl Bryan General Counsel Exercise or conversion · Restricted Stock Units −4,790 14,370
2023-03-15 Whitfield Dianne C. Chief Human Resources Officer Exercise or conversion +4,462 13,185
2023-03-15 Whitfield Dianne C. Chief Human Resources Officer Exercise or conversion · Restricted Stock Units −4,462 13,388
2023-03-15 Trevejo Jose M. Chief Medical Officer Exercise or conversion +7,549 9,153
2023-03-15 Trevejo Jose M. Chief Medical Officer Exercise or conversion · Restricted Stock Units −7,549 22,648
2023-03-15 Mottiwala Aziz Chief Commercial Officer Exercise or conversion +4,790 54,940
2023-03-15 Mottiwala Aziz Chief Commercial Officer Exercise or conversion · Restricted Stock Units −4,790 14,370
2023-03-15 Neervannan Seshadri Chief Operating Officer Exercise or conversion +5,097 56,934
2023-03-15 Neervannan Seshadri Chief Operating Officer Exercise or conversion · Restricted Stock Units −5,097 15,291
2023-03-09 Azamian Bobak R. President/CEO and Board Chair Sale −717 $15.01 $11K 1,088,536
2023-03-08 Azamian Bobak R. President/CEO and Board Chair Sale −4,853 $15.02 $73K 1,089,253
2023-03-08 Whitfield Dianne C. Chief Human Resources Officer Grant or award · Stock Option (right to buy) +42,802 42,802

Page 23 of 24 · 469 trades